Cargando…
NTPDase5/PCPH as a New Target in Highly Aggressive Tumors: A Systematic Review
The protooncogene PCPH was recently identified as being the ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5). This protooncogene is converted into an oncogene by a single base pair deletion, resulting in frame change and producing a premature stop codon, leading to a mutated protein (mt-PCP...
Autores principales: | Bracco, Paula Andreghetto, Bertoni, Ana Paula Santin, Wink, Márcia Rosângela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090452/ https://www.ncbi.nlm.nih.gov/pubmed/25045656 http://dx.doi.org/10.1155/2014/123010 |
Ejemplares similares
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
por: Schultz, Iago Carvalho, et al.
Publicado: (2021) -
The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family
por: MacCARTHY, CAITLIN M., et al.
Publicado: ( 201) -
Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3
por: Baqi, Younis, et al.
Publicado: (2020) -
MSC-Exosomes Carrying miRNA – Could they Enhance Tocilizumab Activity in Neuropathology of COVID-19?
por: Schultz, Iago C., et al.
Publicado: (2022) -
Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5′-Nucleotidase
por: Zanin, Rafael Fernandes, et al.
Publicado: (2012)